Adam Szaronos has been appointed as CEO of Iantrek, succeeding Sean Ianchulev, MD, MPH, according to a press release.
Szaronos has nearly 20 years of experience in the pharmaceutical, medical device and medical technology sectors, with a focus on targeting unmet needs. He has worked on new technology launches in cataract, refractive and vitreoretinal surgery as well as diagnostics and digital health, the release said. He most recently served as CEO and president of Trukera Medical.
Ianchulev will remain as chairman of the board and chief medical officer at Iantrek.
“As millions of patients